Flossmann, O <br/><br/>
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?  [electronic resource] 

 -  Annals of the rheumatic diseases  Jul 2006 
 - 841-4 p.  digital 
<br/><br/> Publication Type: Editorial; Review 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.2005.048900  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Antineutrophil Cytoplasmic--immunology<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>B-Lymphocytes--immunology<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Lymphocyte Depletion<br/>Remission Induction<br/>Rituximab<br/>Vasculitis--drug therapy